Amgen Inc.
DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS
Last updated:
Abstract:
Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
Status:
Application
Type:
Utility
Filling date:
13 May 2020
Issue date:
19 Nov 2020